• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

JPMorgan Claverhouse Investment Trust Plc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider JP Morgan Asset Management (UK) Ltd
Fund Summary The Company aims to provide a combination of capital and income growth from a portfolio consisting mostly of companies listed on the London Stock Exchange. The company's portfolio consists of between 60 and 80 individual equities in which the Manager has high conviction. The company has the ability to use borrowing to gear the portfolio within the range of 5% net cash to 20% geared in normal market conditions.
SEDOL code 0342218
ISIN GB0003422184
Fund code JCHLL
Managers William Meadon, Callum Abbot
Manager Tenure 8 years
Morningstar Category UK Large-Cap Equity
Fund Size Currently unavailable
Fund Type ETF / IT
Management Style Active
Ongoing Charge Figure (OCF) 0.77%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £5.8342
Buy Price £5.9260
Price Date 3rd June 2020
Yield Currently unavailable
Dividend Frequency Quarterly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 7th December 2015
Fund Status OPEN
William Meadon is a Portfolio Managers in JPMorgan’s London-based International Behavioural Finance Team. William Meadon managing director, is head of the Core team in the J.P. Morgan Asset Management European Equity Group. An employee since 1996, William was previously head of UK specialist pension funds at Newton Investment Management Ltd, responsible for pension funds and the Newton Higher Income Fund. Before this, he was a balanced pension fund manager. Prior to Schroders, William was articled to Peat Marwick (now part of KPMG). William obtained a BA (Hons) in Economics from the University of Nottingham and is a qualified Chartered Accountant.

3-year Mean Monthly Return: -0.036%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance -25.39% +5.06% +9.63% +26.16% -7.36% +5.03% +24.11% +23.89% -2.82% +8.84%
Benchmark Performance
(UK Large-Cap Equity)
-18.97% +5.09% +0.61% +18.76% -3.91%
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day 3.45% -15.96% +19.40%
1 week 7.14% +8.88% -1.73%
1 month 10.29% -6.74% +17.03%
3 months -14.76% -11.57% -3.19%
6 months -14.60% -7.55% -7.05%
1 year -9.80% -2.49% -7.31%
3 years -0.58% +1.31% -1.89%
5 years 2.56% +6.27% -3.71%
10 years 8.23% +2.57% +5.66%
YTD -20.76% +2.67% -23.43%
Since inception 11.58% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
30m Gbp Private Placement Mar 2045 9.84%
Royal Dutch Shell PLC B GBR 7.84%
GlaxoSmithKline PLC GBR 7.00%
AstraZeneca PLC GBR 6.79%
British American Tobacco PLC GBR 5.35%
HSBC Holdings PLC GBR 4.61%
JPMorgan Smaller Companies Ord GBR 4.59%
Prudential PLC GBR 3.18%
RELX NV NLD 3.13%
Tesco PLC GBR 3.06%
Dividend Date Per share amount Reinvestment Price
30th April 2020 0.0650 £5.6400
6th February 2020 0.1025 £7.8000
31st October 2019 0.0625 £7.0200
8th August 2019 0.0625 £6.8600
2nd May 2019 0.0625 £7.1200
7th February 2019 0.0950 £7.1000